Acne is not a simple problem. It is a 4-step biological cascade — and each step is a separate potential intervention point.
Step 1: Androgens trigger sebaceous glands to overproduce sebum. Step 2: The sebum-rich environment enables Cutibacterium acnes to proliferate and produce inflammatory metabolites. Step 3: Bacterial virulence factors and immune signalling trigger an inflammatory cascade — cytokines, prostaglandins, neutrophil infiltration. Step 4: Abnormal keratin shedding clogs the follicle — trapping everything, creating an anaerobic breeding ground, turning a minor imbalance into a visible lesion.
Every major acne active — salicylic acid, benzoyl peroxide, niacinamide, azelaic acid — targets a specific step. This article maps exactly where each one works, and shows why multi-step intervention beats single-active approaches.
This article is for educational purposes only. It does not constitute medical advice. Individual skin biology varies.
If you are searching for what causes acne, why you specifically have acne while others don't, what acne bacteria actually does, or where your skincare actives work in the process — this guide covers the complete pathogenesis, from hormonal trigger to visible lesion, with a full map of intervention points.
Acne pathogenesis is the biological sequence of events that transforms a pilosebaceous unit — a hair follicle and its attached sebaceous gland — into an acne lesion. It is not a single disease caused by one factor (dirt, poor hygiene, chocolate). Acne involves multiple interacting biological processes: sebum production, bacterial colonisation by Cutibacterium acnes, immune-mediated inflammation, and follicular keratinisation. The relative contribution of these processes varies between individuals and can differ across acne subtypes.
- Acne is a 4-step biological cascade, not a single disease. Sebum + bacteria + inflammation + keratin accumulation are the four required ingredients.
- Cutibacterium acnes is not the enemy — it is a normal skin bacterium. Virulent strains produce lipases and inflammatory compounds that trigger the cascade.
- Everyone has C. acnes, but not everyone has acne. Susceptibility depends on sebum production rate, bacterial virulence, immune responsiveness, and follicular keratinisation.
- The reason acne persists even with topical treatment is that most actives address one or two mechanisms — if you don't address all four, the cascade rebuilds.
- Hormonal acne is driven by androgen-induced sebum overproduction, producing unusually high bacterial proliferation and proportionally severe inflammation.
- Treating acne requires addressing multiple pathways simultaneously: not just bacteria, not just sebum, not just inflammation — all of them.
- What is acne pathogenesis — and why is it more than one problem?
- The pilosebaceous unit — where acne starts
- Step 1 — Sebum Overproduction: Androgens and the sebaceous gland
- Step 2 — Bacterial Colonisation: Cutibacterium acnes and virulence factors
- Step 3 — Inflammation: The immune cascade that creates visible acne
- Step 4 — Keratin Accumulation and Comedone Formation
- Why some people get acne and others don't — multifactorial susceptibility
- Comedonal vs inflammatory vs hormonal — which mechanisms dominate?
- Where every major acne active intervenes in the cascade
- Why multi-step intervention works better than single actives
- Common myths about acne causes and treatment
- Frequently asked questions
Acne is often treated as if it were a simple infection. It is not. Prescribe antibiotics, and acne improves. Then acne returns because the underlying mechanisms — sebum overproduction, follicular hyperkeratinisation, immune dysregulation — were never addressed. Acne is also often treated as if it were a hygiene problem. It is not. Your skin is not "dirty." Acne results from a specific biological cascade that occurs even in meticulous-skincare users.
Understanding how acne develops helps explain why individuals' acne presentations differ and why single-approach skincare is often less effective than combination approaches. It explains why your acne pattern might differ from someone else's acne: although the same biological processes operate in all skin, different factors can predominate in different individuals. This understanding also helps explain why professional assessment is valuable for moderate-to-severe acne — different presentations may benefit from different approaches.
The Pilosebaceous Unit — Where Acne Starts
Acne does not develop randomly across the skin. It develops in a specific anatomical structure: the pilosebaceous unit — a complex formed by a hair follicle, the hair shaft, and a sebaceous gland that empties into the follicular canal. This unit is the site of acne development because it provides exactly the microenvironment necessary for the cascade: a sebum-rich, partially anaerobic environment where bacteria can proliferate, and a narrow follicular opening where the cascade consequences — keratin accumulation, sebum retention, inflammatory mediators — become trapped.
Sebaceous glands are found throughout the body, but the pilosebaceous units most prone to acne are located in areas with the highest sebaceous gland density: the face (T-zone), upper back, and chest. These are also the areas with the highest concentration of androgens — the hormonal trigger that accelerates sebum production. This explains the distribution pattern of acne, which is not random.
The follicular epithelium — the lining of the hair follicle — is lined with keratinocytes that normally shed individually and exit the follicle, leaving an empty channel. In acne-prone skin, this shedding becomes dysregulated: keratinocytes detach in clumps, accumulate, and compress into a plug. Combined with sebum and bacteria, this plug traps inflammatory mediators and creates the anaerobic conditions that enable C. acnes to proliferate.
Acne predominantly affects areas with the highest sebaceous gland density and the highest androgen sensitivity: the face (especially the T-zone), upper back, and chest. Acne is rare on the palms, soles, shins, or forearms — areas with minimal sebaceous gland density. This anatomical specificity is fundamental: acne cannot develop where there are no pilosebaceous units.
Step 1 — Sebum Overproduction: Androgens and the Sebaceous Gland
The first step of acne pathogenesis is not bacterial. It is hormonal.
Sebaceous glands are androgen-responsive tissues. The androgens primarily responsible are testosterone and dihydrotestosterone (DHT) — specifically, DHT is the more potent activator at the cellular level. DHT binds androgen receptors (AR) on sebocytes — the specialized cells that produce sebaceous lipids. This receptor activation upregulates the sebocytes' lipogenic gene expression, increasing the synthesis and secretion of sebaceous lipids — triglycerides, wax esters, squalene, and cholesterol esters.
In puberty, circulating androgen levels rise sharply, activating sebaceous glands throughout the body. Sebaceous-gland activity increases during this period, contributing to increased sebum production. This hormonal activation of sebaceous glands is the reason acne typically begins in adolescence in susceptible individuals — not merely because of increased bacterial load or suddenly appearing keratinisation, but because of the hormonal activation of sebaceous tissue producing higher quantities of sebum.
High sebum production is necessary but not sufficient for acne. Many people with exceptionally oily skin have no acne. What matters is that sebum creates a lipid-rich microenvironment where acne-associated strains of C. acnes can proliferate exponentially. Without abundant sebum, the bacteria cannot establish the population density necessary for the inflammatory cascade. With abundant sebum, the environment transitions from sparse colonisation to aggressive bacterial proliferation — Step 2.
Step 2 — Bacterial Colonisation: Cutibacterium Acnes and Virulence Factors
Cutibacterium acnes (formerly named Propionibacterium acnes) is a gram-positive anaerobic bacterium that colonises human skin as part of the normal microbiota. It is present on virtually all humans from infancy onward. It is not inherently pathogenic — healthy skin tolerates C. acnes without developing acne.
The bacteria becomes acne-associated when it proliferates in a sebum-rich, anaerobic microenvironment. The amount and composition of C. acnes within the follicular environment can influence inflammatory signalling and bacterial metabolism, but acne cannot be explained by bacterial quantity alone.
C. acnes virulence factors — what makes certain strains acne-causing
Not all C. acnes strains cause acne. Acne-associated strains carry specific virulence factors that non-acne-associated strains lack or produce at lower levels. The primary virulence factors are:
| Virulence Factor | Mechanism | Acne Relevance |
|---|---|---|
| Lipases | Enzymes that cleave sebaceous triglycerides into free fatty acids — inflammatory compounds that directly irritate follicular epithelium and recruit immune cells | Strong — free fatty acids are potent inflammatory mediators; directly damage follicular lining |
| Hyaluronidase | Enzyme that degrades hyaluronic acid in the basement membrane separating follicle from dermis — enabling bacterial dissemination and deeper inflammation | Moderate — enables progression from superficial comedone to deeper cystic lesions |
| Lipoteichoic Acid (LTA) | Cell wall component of gram-positive bacteria — binds toll-like receptors (TLR) on keratinocytes and immune cells, triggering inflammatory signalling cascades | Strong — initiates the immune cascade that creates visible inflammation |
| CAMP Factors | Secreted factors that damage cell membranes — enhance bacterial survival within follicular epithelium and immune cells | Moderate — enhance bacterial persistence |
| Coagulase | Enzyme that converts fibrinogen to fibrin — creates fibrin cloaks that protect bacteria from antibiotics and immune attack | Moderate — contributes to antibiotic resistance in persistent acne |
Acne-associated C. acnes strains show measurable differences in lipase production, TLR ligand profiles, and hyaluronidase expression compared to non-acne strains. This is one reason some people develop acne while others with identical sebum levels do not: the bacterial strains colonising their pilosebaceous units differ in virulence factor expression. Genetic factors, microbiota seeding in infancy and early childhood, and immune history all influence which strains establish dominance.
Step 3 — Inflammation: The Immune Cascade That Creates Visible Acne
The presence of sebum-fed C. acnes in a follicle does not automatically produce the visible red, swollen, painful bump of inflammatory acne. The visual and symptomatic manifestations of acne are created by the inflammatory cascade — the immune system's response to bacterial virulence factors and follicular damage.
The inflammatory cascade: Step by step
Step 3a — Pattern Recognition: Bacterial lipoteichoic acid (LTA) and other PAMPs (pathogen-associated molecular patterns) bind to toll-like receptors (particularly TLR2 and TLR4) on follicular keratinocytes and dermal immune cells. This binding is "pattern recognition" — the immune system identifies molecular signatures associated with bacterial presence.
Step 3b — Signal Transduction: TLR binding triggers intracellular signalling cascades — MyD88 and TRIF pathways converge on NF-κB and MAPK activation, translating extracellular bacterial signals into intracellular inflammatory gene expression.
Step 3c — Cytokine Production: Keratinocytes and immune cells produce inflammatory cytokines: IL-6, IL-8, TNF-α, and IL-1β. These cytokines recruit additional immune cells and amplify the inflammatory response. Free fatty acids released by bacterial lipases further amplify this response — acting as additional TLR ligands.
Step 3d — Immune Cell Recruitment: IL-8 and other chemokines recruit neutrophils into the follicle. Neutrophils arrive to kill bacteria but cause collateral damage to follicular epithelium in the process. Macrophages and dendritic cells also infiltrate, presenting bacterial antigens and further amplifying immune signalling.
Step 3e — Prostaglandin Production: Immune cells produce prostaglandins (PGE2, PGF2α) — lipid mediators that increase vascular permeability, pain sensation, and vasodilation. This creates the visible redness and swelling characteristic of inflammatory acne.
What you see as a red pimple — the visual manifestation of acne — is not the bacteria. It is the immune response to the bacteria. The redness is from vasodilation and increased blood flow driven by prostaglandins and cytokines. The swelling is from vascular permeability and tissue edema. The pain is from prostaglandin-mediated nociceptor activation and high pressure from accumulated neutrophils and edema fluid. Removing or suppressing the inflammatory cascade suppresses the visible lesion — even if the bacteria remain. This is why topical anti-inflammatory actives (Niacinamide, Azelaic Acid) can reduce the appearance of acne even without directly killing bacteria.
Step 4 — Keratin Accumulation and Comedone Formation
The fourth mechanism is not sebum overproduction, bacterial virulence, or immune inflammation. It is abnormal keratin shedding within the follicle — a dysregulation of the normal process by which follicular epithelial cells shed and exit.
Normal follicular keratinisation vs hyperkeratinisation
In healthy skin, follicular keratinocytes detach individually at regular intervals and exit through the follicular opening to the skin surface. This process is continuous and maintains the follicle as an open channel. In acne-prone skin, this process becomes dysregulated: keratinocytes detach abnormally — in clumps rather than individually — accumulate within the follicle, and compress into a plug.
This dysregulation is not caused by excess keratin production. It is caused by dysregulated keratinocyte adhesion and shedding — the interconnections between cells and the signals that normally govern their detachment and migration are disrupted. The result is keratin impaction rather than normal drainage.
When keratin impaction combines with sebum and bacteria in a partially anaerobic follicle, the result is a comedone — a sebaceous plug containing sebum, keratin, bacterial cells, and lipid oxidation byproducts (which appear black in blackheads due to oxidation of lipids and melanin, not dirt).
Why Keratin Dysregulation Matters in Step 4
Keratin impaction is the reason:
- Sebum-rich skin can remain clear if keratin shedding is normal (sebum alone cannot cause acne)
- BHA and AHA actives work — they dissolve keratin plugs, re-opening the follicle and enabling drainage
- Antibiotics alone often fail long-term — they kill bacteria but don't address the follicular plug that re-enables colonisation
- Multi-step therapy (antbiotics + keratin-dissolution + sebum control) works better than monotherapy
A comedone is not simply compressed sebum. It is a complex mixture: sebaceous lipids, accumulated keratinocytes and cellular debris, bacterial cells, oxidised lipids, melanin, and free fatty acids from bacterial lipase activity. This is why simple "pore strips" and mechanical extraction often fail — you may remove the surface material, but the underlying plug structure remains intact within the follicle.
Why Some People Get Acne and Others Don't — Multifactorial Susceptibility
All four mechanisms must be present for acne to develop. A person can possess three of the four and remain clear. Understanding the distribution of these factors among different people explains why acne prevalence and severity vary dramatically despite similar sebum production rates and bacterial colonisation.
| Susceptibility Factor | Genetic / Innate | Environmental / Modifiable | Acne Outcome |
|---|---|---|---|
| Androgen Sensitivity | High genetic component — AR expression varies between individuals; acne-prone families show higher AR sensitivity | Minor — diet, stress may modulate slightly | High sensitivity → more sebum output → higher acne risk |
| Follicular Keratinisation | Genetic predisposition — some individuals have inherently dysregulated follicular keratinocyte shedding | Stress and hormonal fluctuations exacerbate | Dysregulation → keratin impaction → acne risk |
| C. acnes Strain Virulence | Microbiota composition inherited partially through family; early-life seeding influences | Antibiotic history, hygiene practices may shift strains | Virulent strains → greater lipase/inflammatory output → worse acne |
| Immune Responsiveness | Genetic — innate immune TLR variants affect inflammatory response magnitude | Stress, sleep, diet may modulate | High responsiveness → greater inflammatory cascade → visible acne despite low bacterial load |
The practical consequence: two people with identical sebum levels and identical C. acnes colonisation may have vastly different acne severity. One may have normal follicular keratinisation, low-virulence bacterial strains, and dampened immune responsiveness → clear skin. Another may have hyperkeratinisation, virulent strains, and heightened immune responses → severe acne. The differences in all four mechanisms create the spectrum from clear to cystic acne.
Comedonal vs Inflammatory vs Hormonal — Which Mechanisms Dominate?
| Acne Type | Dominant Mechanism | Clinical Appearance | Treatment Focus |
|---|---|---|---|
| Comedonal Acne | Keratin accumulation + sebum. Minimal immune activation. Bacteria present but limited virulence expression or immune response. | Blackheads and whiteheads. Minimal redness. Non-painful. | Keratin-dissolution actives: BHA (Salicylic Acid), AHA (Glycolic/Lactic Acid) · Retinoids · Minimal antibiotics needed |
| Inflammatory Acne | Active immune cascade. Red, swollen, painful lesions. Dominated by cytokine and prostaglandin production. Bacterial virulence and/or immune responsiveness high. | Papules, pustules, nodules. Visible redness. Pain/tenderness. Can be post-comedonal or arise from non-comedonal follicles. | Anti-inflammatory actives: Niacinamide, Azelaic Acid · Antibiotics · Retinoids · SPF (UV inflammation co-trigger) |
| Hormonal Acne | Androgen-driven sebum overproduction. Often mixed comedonal and inflammatory. Typically jawline, chin, lower face. Cyclic (worsens during luteal phase in menstruating individuals). | Mixed — comedones in sebaceous areas + inflammatory lesions · Distribution pattern is jawline/chin-focused · Predictable timing relative to menstrual cycle | Sebum regulation essential: hormonal contraception, spironolactone, isotretinoin · Plus multi-mechanism topical support |
| Cystic/Nodular Acne | All mechanisms at severe intensity. Bacteria deep in follicle with hyaluronidase enabling dermal invasion. Intense immune response. Potential for permanent scarring. | Large, painful, deep nodules and cysts. Often not come to a head. Significant inflammation and potential for scarring. | Often requires systemic treatment: isotretinoin most effective · Antibiotics (but limited efficacy alone) · Oral anti-inflammatory support |
Where Every Major Acne Active Intervenes in the Cascade
Each major acne active targets one or more of the four mechanisms. Understanding this map explains why some combinations work while others are redundant, and why multi-mechanism therapy beats monotherapy.
| Active Ingredient | Primary Target | Mechanism of Action | Why It Works |
|---|---|---|---|
| Benzoyl Peroxide | Step 2 — Bacteria | Oxidative damage to C. acnes cell structures; reduces bacterial lipase and virulence gene expression | Directly reduces bacterial load and virulence; one of the few actives that actually kills bacteria rather than inhibiting |
| Salicylic Acid (BHA) | Step 4 — Keratin | Dissolves sebaceous lipids and intercellular lipids binding keratinocytes; normalises follicular keratinisation | Opens comedones by dissolving the plug; prevents new plug formation |
| Glycolic Acid (AHA) | Step 4 — Keratin | Disrupts desmosomes (cell-cell junctions) in the stratum corneum and follicular epithelium; accelerates keratinocyte shedding | Accelerates normal keratin turnover; prevents accumulation |
| Azelaic Acid | Steps 2 + 3 | Tyrosinase inhibition (reduces bacterial lipase expression) + anti-inflammatory (reduces IL-6, IL-8) | Dual-mechanism — addresses bacteria and inflammation simultaneously |
| Niacinamide | Step 3 — Inflammation | Reduces sebaceous lipase activity; modulates IL-6 and IL-8 production; reduces neutrophil infiltration | Reduces the inflammatory cascade magnitude without killing bacteria; can suppress acne progression even with bacteria present |
| Retinoids (Tretinoin, Adapalene) | Steps 1 + 4 | Reduce sebaceous gland size and sebum output; normalise follicular keratinisation via RAR/RXR signaling | Address both sebum overproduction and keratin dysregulation — two fundamental mechanisms |
| Isotretinoin (Accutane) | ALL FOUR steps | Suppresses sebaceous gland development; reduces sebum to near-zero; normalises follicular keratinisation; suppresses immune responsiveness | Unique ability to address all four mechanisms simultaneously — explain why it is the most effective acne treatment and why relapse is rare after treatment |
| Hormonal agents (OCPs, Spironolactone) | Step 1 — Sebum | Reduce circulating androgen levels or block AR at the tissue level | Particularly effective for hormonal acne; less effective for acne driven by follicular keratinisation or bacterial virulence |
| Antibiotics (Doxycycline, Clindamycin) | Step 2 — Bacteria | Kill or inhibit C. acnes; also have anti-inflammatory effects via reduced TLR signaling | Effective short-term but limited long-term efficacy because they don't address the other three mechanisms; bacterial resistance develops over months to years |
Why Multi-Step Intervention Works Better Than Single Actives
The data is consistent: acne management protocols that address multiple mechanisms simultaneously show better efficacy than those targeting one mechanism, even at high concentrations.
Clinical Evidence for Multi-Mechanism Therapy
Benzoyl Peroxide + BHA: Addresses bacteria (Step 2) + keratin (Step 4). Superior to either alone. The BHA opens the comedone, enabling benzoyl peroxide to penetrate deeper and contact bacteria that would otherwise be inaccessible.
Benzoyl Peroxide + Niacinamide: Addresses bacteria (Step 2) + inflammation (Step 3). Combination reduces both bacterial load and inflammatory markers more effectively than benzoyl peroxide alone, likely because niacinamide-mediated reduction in IL-8 production reduces the recruitment of additional immune cells that would otherwise interfere with benzoyl peroxide efficacy.
Retinoid + BHA/AHA: Addresses sebum + keratin (Steps 1 and 4). Particularly synergistic because retinoids address the underlying dysregulation of keratin shedding while BHA/AHA provide immediate exfoliation of accumulated plug material.
Spironolactone (systemic) + Topical Multi-Mechanism: The most evidence-supported approach for hormonal acne. Systemic treatment reduces the androgen-driven sebum overproduction at its source; topical therapy addresses the inflammation, bacteria, and keratin accumulation that persist even as sebum normalises.
Common Myths About Acne Causes and Treatment
Acne is not caused by dirt. Cutibacterium acnes is a normal skin resident on all humans. Acne develops from a specific biological cascade: sebum overproduction, bacterial virulence, inflammation, and keratin dysregulation. Over-cleansing and harsh cleansing can paradoxically worsen acne by disrupting skin barrier integrity, triggering reactive sebum production, and increasing follicular irritation.
Fact: Acne is a biological pathogenic cascade, not a hygiene problem. Gentle, non-stripping cleansing is preferable to harsh cleansing that damages the barrier.
The connection between specific foods and acne has been extensively studied. Strong associations exist for high-glycemic foods and dairy products, likely through hormone and metabolite pathways affecting sebaceous gland function. The "greasy food → greasy skin → acne" hypothesis has never been supported by evidence — dietary fat does not directly translate to sebaceous lipid production.
Fact: High-glycemic index foods and dairy show weak-to-moderate associations with acne in some studies; other foods show no consistent association. The pathway is hormonal/metabolic, not dietary fat → skin oil.
Antibiotics kill bacteria — they are effective in the short term. However, they do not address sebum overproduction, follicular hyperkeratinisation, or the underlying immune dysregulation. Additionally, C. acnes develops antibiotic resistance over months to years of continuous use. Long-term acne management requires addressing multiple mechanisms, not just bacterial load.
Fact: Antibiotics are effective short-term but often fail long-term due to incomplete mechanism coverage and bacterial resistance development. Combination therapy addressing all four mechanisms is more sustainable.
Frequently Asked Questions
- Dessinioti, C., et al. (2019). Understanding the pathophysiology of acne vulgaris. Clinical, Cosmetic and Investigational Dermatology, 12, 393–404.
- Williams, M.R., et al. (2023). Acne vulgaris. Nature Reviews Disease Primers, 9(1), 6.
- Dreno, B., et al. (2018). Acne pathogenesis and treatment. Journal of the European Academy of Dermatology and Venereology, 32(S2), 8–15.
- Paraskevopoulos, D., & Shalita, A.R. (2014). Evidence-based acne treatment. Clinics in Dermatology, 32(3), 329–337.
- Thiboutot, D., et al. (2015). Acne management: Current standards and future considerations. Journal of the American Academy of Dermatology, 72(5 Suppl), S23–S24.
- Del Rosso, L.M., & Kim, G. (2009). Oral antibiotics for acne: Emerging resistance. Dermatologic Clinics, 27(1), 6–7.
- Gollnick, H.P., et al. (2016). Pathogenesis and pathophysiology of acne. Seminars in Cutaneous Medicine and Surgery, 35(2 Suppl 1), S22–S26.
- Navarrete-Solís, H., et al. (2012). A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of functional hyperpigmentation. Dermatology Research and Practice, 2012, 379173.
© 2026 Boldpurity · For educational purposes only · Not to be reproduced without permission.
